首页> 外文OA文献 >Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies

【2h】

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies

机译：由于CFHR1 / CFHR3的纯合缺失和CFH抗体的存在，在移植后Ahus中具有Belatacept和Eculizumab的有效免疫抑制作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Johannes Münch; Anette Bachmann; Maik Grohmann; Christof Mayer; Michael Kirschfink; Tom H Lindner; Carsten Bergmann; Jan Halbritter;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1 / CFHR3 and the presence of CFH antibodies [J] . Carsten Bergmann, Johannes Münch, Tom H Lindner, Clinical kidney journal. . 2017,第6期

机译：由于CFHR1 / CFHR3的纯合缺失和CFH抗体的存在，在移植后aHUS中使用贝拉西普和依库丽单抗进行有效的免疫抑制治疗
2. Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies [J] . Münch Johannes, Bachmann Anette, Grohmann Maik, Clinical kidney journal. . 2017,第6期

机译：由于CFHR1 / CFHR3的纯合缺失和CFH抗体的存在，在移植后aHUS中使用belatacept和依库丽单抗进行有效的免疫抑制治疗
3. ACUTE POSTTRANSPLANT AHUS DUE TO A HOMOZYGOUS DELETION OF CFHR1/CFHR3 WITH CFH-AUTOANTIBODIES MANAGED BY A CNI-FREE REGIMEN WITH BELATACEPT AND ECULIZUMAB [J] . Muench J., Bachmann A., Lindner T. H., Transplant international : . 2016,第Suppla3期

机译：急性后移植后烧伤，原因是无氯的CNI方案使用贝拉替普定和依考珠单抗控制CFHR1 / CFHR3与CFH-抗体的同质清除
4. Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies [O] . Johannes Münch, Anette Bachmann, Maik Grohmann, 2017

机译：由于CFHR1 / CFHR3的纯合缺失和CFH抗体的存在在移植后aHUS中使用belatacept和依库丽单抗进行有效的免疫抑制治疗
5. Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH/CFHR1 hybrid gene [O] . Román-Ortiz, E., Mendizabal Oteiza, S., Pinto, Sheila, 2014

机译：依库丽单抗CFH / CFHR1杂合基因长期治疗aHUS小儿肾移植

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies

著录项

引文网络

相似文献

相关主题

期刊订阅